Seeking Alpha

United Therapeutics (UTHR) dives 11.8% after yesterday saying that the FDA has turned down the...

United Therapeutics (UTHR) dives 11.8% after yesterday saying that the FDA has turned down the company's new drug application for treprostinil, an oral treatment for high blood pressure. The agency is uncertain whether another study would help change its mind, but said that if UTHR does decide on a further trial, it should consider a fixed dose design and more frequent dosing. (PR)
From other sites
Comments (1)
  • alph124
    , contributor
    Comments (30) | Send Message
     
    Unusual to hear a CEO talk about how great the business on a conference call only days before an earnings release.
    24 Oct 2012, 08:45 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs